Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a viral respiratory disease that spreads rapidly, reaching pandemic status, causing the collapse of numerous health systems, and a strong economic and social impact. The treatment so far has not been well established and there are several clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertanha, Matheus, Rodrigues, Lenize da Silva, Mellucci Filho, Pedro Luciano, Moroz, Andrei, Pardini, Maria Inês de Moura Campos, Sobreira, Marcone Lima, Durigon, Edison Luiz, Machado, Rafael Rahal Guaragna, Grotto, Rejane Maria Tommasini, de Lima, Marcelo Andrade, Nader, Helena Bonciani, de Moraes, Marli Leite, Barbosa, Alexandre Naime, Medolago, Natália Bronzatto, Cardoso, Fábio Florença, Magro, Angelo José, Carvalho, Cristiane Rodrigues Guzzo, de Moraes, Leonardo Nazário, Alvarado, Rita de Cássia, Nunes, Helga Caputo, de Campos, Gustavo Constantino, Grillo, Vinicius Tadeu Ramos da Silva, Sertorio, Nathalia Dias, Fortaleza, Carlos Magno Castelo Branco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702290/
https://www.ncbi.nlm.nih.gov/pubmed/34941114
http://dx.doi.org/10.1097/MD.0000000000028288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702290/
https://www.ncbi.nlm.nih.gov/pubmed/34941114
http://dx.doi.org/10.1097/MD.0000000000028288

Ejemplares similares